Testing vaccines and biologics against dangerous infectious diseases in primates
Official title: Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates
Funded at Battelle Centers/pub Hlth Res & Evaluatn · NIH-10712849 · Data updated 2026-11-12
This study is testing new vaccines to see if they are safe and work well against serious infections, like the Nipah virus, so that one day, people can have better protection against these diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | August 1, 2019 |
| Project end | December 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $2,467,841 |
| NIH project number | 272201800013I-P00006-759301900131-2 |
| Project ID | NIH-10712849 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be individuals at risk of exposure to BSL-4 pathogens or those in need of new vaccine options for serious infectious diseases.
✕Less likely to help
Patients who are not at risk for BSL-4 pathogens or who have existing effective vaccines may not receive benefit from this research.
What this research studies
This research focuses on evaluating the safety and effectiveness of new vaccines and biologics designed to combat serious infectious diseases. Using non-human primates, the study conducts feasibility assessments and prepares necessary documentation for regulatory approval of these medical countermeasures. Patients may benefit from the eventual development of vaccines that could protect against severe diseases like Nipah virus. The research aims to ensure that new treatments are both safe and effective before they are made available to the public.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines against highly infectious and dangerous diseases.
How similar studies have gone: Other research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
-
Battelle Centers/pub Hlth Res & Evaluatn
Columbus, United States Active
Researchers
- Principal investigator: Rudge, Thomas — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Rudge, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.